Future Science Group
Browse
IMAGE
Supplementary Figure S1.tif (271.41 kB)
IMAGE
Supplementary Figure S2.tif (1.34 MB)
IMAGE
Supplementary Figure S3.tif (4.47 MB)
IMAGE
Supplementary Figure S4.tif (487.98 kB)
IMAGE
Supplementary Figure S5.tif (353.44 kB)
IMAGE
supplementary Figure S6.tif (2.22 MB)
IMAGE
Supplementary Figure S7.tif (322.42 kB)
IMAGE
Supplementary Figure S8.tif (205.67 kB)
DOCUMENT
Supplementary Information 10_ refs - com autores.docx (2.23 MB)
1/0
9 files

Poly(2-ethyl-2-oxazoline)–IR780 conjugate nanoparticles for breast cancer phototherapy - Supplementary dataset

dataset
posted on 2023-02-21, 12:01 authored by Catia G Alves, Rita Lima-Sousa, Bruna L Melo, Paula Ferreira, Andre F Moreira, Ilıdio J Correia, Duarte de Melo-Diogo

Aims: To address the limitations of IR780 by preparing hydrophilic polymer–IR780 conjugates and to

employ these conjugates in the assembly of nanoparticles (NPs) intended for cancer photothermal

therapy. Materials & methods: The cyclohexenyl ring of IR780 was conjugated for the first time with

thiol-terminated poly(2-ethyl-2-oxazoline) (PEtOx). This novel poly(2-ethyl-2-oxazoline)-IR780 (PEtOx-

IR) conjugate was combined with D-α-tocopheryl succinate (TOS), leading to the assembly of mixed

NPs (PEtOx-IR/TOS NPs). Results: PEtOx-IR/TOS NPs displayed optimal colloidal stability as well as

cytocompatibility in healthy cells at doses within the therapeutic range. In turn, the combination of

PEtOx-IR/TOS NPs and near-infrared light reduced heterotypic breast cancer spheroid viability to just 15%.

Conclusion: PEtOx-IR/TOS NPs are promising agents for breast cancer photothermal therapy.

Funding

Fundação para a Ciência e a Tecnologia, (Grant / Award Number:'2021.00590.CEECIND','2021.06044.BD','2022.06320.PTDC ','PTDC/BTA-BTA/0696/2020 ','SFRH/BD/144922/2019 ','SFRH/BD/145386/2019','UIDB/00709/2020','UIDP/00709/2020')

History

Usage metrics

    Nanomedicine

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC